Application of antibiotics before 3 years of age increases the risk of childhood overweight and obesity

Tian,Jiuzhen; Liu,Honghua; Guo,Hua; Han,Weiping; Ding,Hui; Chen,Tong

doi:10.3892/etm.2020.9488

Application of antibiotics before 3 years of age increases the risk of childhood overweight and obesity

Authors:
- Jiuzhen Tian
- Honghua Liu
- Hua Guo
- Weiping Han
- Hui Ding
- Tong Chen
View Affiliations

Affiliations: Department of Pediatrics, Dongying People's Hospital, Dongying, Shandong 257000, P.R. China, Operation Room, Dongying People's Hospital, Dongying, Shandong 257000, P.R. China
Published online on: November 19, 2020 https://doi.org/10.3892/etm.2020.9488
Article Number: 56

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Childhood obesity and antibiotics abuse have become global health problems. It is necessary to explore the correlation between application of antibiotics for children under 3 and the risk of overweight and obesity in children. In the present study, young children aged 3 (36‑38 months) were investigated using a face‑to‑face questionnaire survey. These children were admitted to Dongying City Children's Hospital from December 2017 to May 2019, and the effective sample size was 4,258. According to the body mass index (BMI), young children were divided into two groups, including emaciation and normal group as well as overweight and obesity group. Univariate analysis was performed to identify the possible influencing factors between the two groups using chi‑square test. A difference of P<0.05 indicated statistical significance of a certain factor between the two groups, which could be adopted as an influencing factor in Logistic regression analysis. In addition, odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were employed to quantify the correlation of antibiotic application with the risk of overweight and obesity. A total of 3,322 young children (78.0%) were included in the antibiotic group while the remaining 936 (22.0%) were enrolled in the non‑antibiotic group. Logistic regression analysis revealed that antibiotic application increased the risk of overweight and obesity among the 3‑year‑old young children (OR, 1.44; 95% CI, 1.03‑2.01). In addition, application of antibiotics for five times or higher significantly increased the risk of overweight and obesity (OR, 1.73; 95% CI, 1.07‑2.80), and such risks were more significant in children who were administered antibiotics for the first time within 6 months of age (OR, 1.71; 95% CI, 1.08‑2.69). The application of antibiotics in infants and young children was thus revealed to increase the risk of overweight and obesity at the age of 3 in a frequency‑dependent manner.

View Figures

View References

1	Zhang T, Smith MA, Camp PG, Shajari S, MacLeod SM and Carleton BC: Prescription drug dispensing profiles for one million children: A population-based analysis. Eur J Clin Pharmacol. 69:581–588. 2013.PubMed/NCBI View Article : Google Scholar
2	Seekatz AM and Young VB: Clostridium difficile and the microbiota. J Clin Invest. 124:4182–4189. 2014.PubMed/NCBI View Article : Google Scholar
3	Tilg H and Adolph TE: Influence of the human intestinal microbiome on obesity and metabolic dysfunction. Curr Opin Pediatr. 27:496–501. 2015.PubMed/NCBI View Article : Google Scholar
4	Bailey LC, Forrest CB, Zhang P, Richards TM, Livshits A and DeRusso PA: Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr. 168:1063–1069. 2014.PubMed/NCBI View Article : Google Scholar
5	Saari A, Virta LJ, Sankilampi U, Dunkel L and Saxen H: Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life. Pediatrics. 135:617–626. 2015.PubMed/NCBI View Article : Google Scholar
6	GBD 2015 Obesity Collaborators. Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, Marczak L, Mokdad AH, Moradi-Lakeh M, et al: Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 377:13–27. 2017.PubMed/NCBI View Article : Google Scholar
7	Kyrgiou M, Kalliala I, Markozannes G, Gunter MJ, Paraskevaidis E, Gabra H, Martin-Hirsch P and Tsilidis KK: Adiposity and cancer at major anatomical sites: Umbrella review of the literature. BMJ. 356(j477)2017.PubMed/NCBI View Article : Google Scholar
8	Ajslev TA, Andersen CS, Gamborg M, Sørensen TI and Jess T: Childhood overweight after establishment of the gut microbiota: The role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int J Obes (Lond). 35:522–529. 2011.PubMed/NCBI View Article : Google Scholar
9	Trasande L, Blustein J, Liu M, Corwin E, Cox LM and Blaser MJ: Infant antibiotic exposures and early-life body mass. Int J Obes (Lond). 37:16–23. 2013.PubMed/NCBI View Article : Google Scholar
10	Edmonson MB and Eickhoff JC: Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatr. 171:150–156. 2017.PubMed/NCBI View Article : Google Scholar
11	Wang W: Pediatrics. 9th edition. People's Medical Publishing House, 2018.
12	Li H, Ji CY, Zong XN and Zhang YQ: Body mass index growth curves for Chinese children and adolescents aged 0 to 18 years. Zhonghua Er Ke Za Zhi. 47:493–498. 2009.PubMed/NCBI(In Chinese).
13	Shi CM, Li XL, Dong J, Zhang CM, Tong ML, Guo XR and Zhang M: A survey of 1~7 year old children's eating behavior and its association with children's physical development. Zhonghua Shi Yong Er Ke Lin Chuang Za Zhi. 31:840–845. 2016.(In Chinese).
14	Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 894:i–xii, 1-253. 2000.PubMed/NCBI
15	Ogden CL, Carroll MD, Kit BK and Flegal KM: Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 307:483–490. 2012.PubMed/NCBI View Article : Google Scholar
16	Mbakwa CA, Scheres L, Penders J, Mommers M, Thijs C and Arts IC: Early life antibiotic exposure and weight development in children. J Pediatr. 176:105–113.e2. 2016.PubMed/NCBI View Article : Google Scholar
17	Azad MB, Bridgman SL, Becker AB and Kozyrskyj AL: Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int J Obes (Lond). 38:1290–1298. 2014.PubMed/NCBI View Article : Google Scholar
18	Grijalva CG, Nuorti JP and Griffin MR: Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 302:758–766. 2009.PubMed/NCBI View Article : Google Scholar
19	Paul IM, Maselli JH, Hersh AL, Boushey HA, Nielson DW and Cabana MD: Antibiotic prescribing during pediatric ambulatory care visits for asthma. Pediatrics. 127:1014–1021. 2011.PubMed/NCBI View Article : Google Scholar
20	Dubos R, Savage D and Schaedler R: Biological Freudianism. Lasting effects of early environmental influences. Pediatrics. 38:789–800. 1966.PubMed/NCBI
21	Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Bäckhed HK, Gonzalez A, Werner JJ, Angenent LT, Knight R, et al: Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 150:470–480. 2012.PubMed/NCBI View Article : Google Scholar
22	Gaskins HR, Collier CT and Anderson DB: Antibiotics as growth promotants: Mode of action. Anim Biotechnol. 13:29–42. 2002.PubMed/NCBI View Article : Google Scholar
23	Cho I, Yamanishi S, Cox L, Methé BA, Zavadil J, Li K, Gao Z, Mahana D, Raju K, Teitler I, et al: Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 488:621–626. 2012.PubMed/NCBI View Article : Google Scholar
24	Cox LM, Yamanishi S, Sohn J, Alekseyenko AV, Leung JM, Cho I, Kim SG, Li H, Gao Z, Mahana D, et al: Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 158:705–721. 2014.PubMed/NCBI View Article : Google Scholar
25	Angelakis E, Merhej V and Raoult D: Related actions of probiotics and antibiotics on gut microbiota and weight modification. Lancet Infect Dis. 13:889–899. 2013.PubMed/NCBI View Article : Google Scholar
26	Esposito S, Castellazzi L and Garbarino F: Can probiotic administration during pregnancy and the first year of life effectively reduce the risk of infections and allergic diseases in childhood? J Biol Regul Homeost Agents. 28:565–573. 2014.PubMed/NCBI
27	Barczynska R, Bandurska K, Slizewska K, Litwin M, Szalecki M, Libudzisz Z and Kapusniak J: Intestinal Microbiota, obesity and prebiotics. Pol J Microbiol. 64:93–100. 2015.PubMed/NCBI
28	Million M, Angelakis E, Paul M, Armougom F, Leibovici L and Raoult D: Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb Pathog. 53:100–108. 2012.PubMed/NCBI View Article : Google Scholar
29	Yin YN, Yu QF, Fu N, Liu XW and Lu FG: Effects of four Bifidobacteria on obesity in high-fat diet induced rats. World J Gastroenterol. 16:3394–3401. 2010.PubMed/NCBI View Article : Google Scholar
30	Park DY, Ahn YT, Park SH, Huh CS, Yoo SR, Yu R, Sung MK, McGregor RA and Choi MS: Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One. 8(e59470)2013.PubMed/NCBI View Article : Google Scholar
31	Mekkes MC, Weenen TC, Brummer RJ and Claassen E: The development of probiotic treatment in obesity: A review. Benef Microbes. 5:19–28. 2014.PubMed/NCBI View Article : Google Scholar